Manufacturing Delays Overshadow Bullish Q2, Valuation Gap Remains Wide

What happened

AST SpaceMobile's Q2 call was its most bullish yet, with management highlighting multi-billion-dollar revenue potential across defense, B2B, IoT, and other segments, including a raised $3 billion annual defense base case. However, possible manufacturing delays impacted near-term satellite launch cadence, prompting the Seeking Alpha author to downgrade the stock to a buy with a fair value of $165 per share, still far above the current price. The latest DeepValue master report, based on filings through August 2026, rates ASTS a WAIT, with a base-case implied value of $63, a bear case of $40, and a bull case of $85, reflecting zero recognized SpaceMobile Service revenue and only 6.6% of the $1.2 billion remaining performance obligations converting within 12 months. The gap between the article's $165 fair value and the master report's $63 base case stems from aggressive assumptions about defense and B2B revenue that are not yet visible in contractual backlog or commercial service proof. Near-term, the key checkpoints remain the launch and operational status of BlueBirds 14-16 by late November 2026, concrete beta-service disclosure, and first SpaceMobile Service revenue by early 2027.

Implication

Hold the stock only if the position is already small; do not chase above $78, which is the master report's trim threshold. The article's $165 fair value depends on defense and B2B assumptions that are not yet supported by backlog conversion, given only 6.6% of the $1.2 billion performance obligations is expected to convert within 12 months. The master report's base case of $63 suggests limited upside from the current price of about $62 until revenue proof emerges. The critical 90-day checkpoints are: BlueBirds 14-16 must launch and become operational by late November 2026, and AST must disclose concrete beta-service progress beyond generic testing language. Failure to hit those or to record first SpaceMobile Service revenue by early 2027 could push the stock toward the $40 bear case, while success may justify only the $85 bull case near term, still well below the article's target.

Thesis delta

The Seeking Alpha article slightly lowers its rating to buy from strong buy due to short-term manufacturing delays, but maintains a high fair value of $165 based on aggressive defense and B2B revenue assumptions. The DeepValue master report remains a WAIT, with a base-case value of $63 and limited upside until commercial service revenue is proven. Our blended thesis does not change: near-term execution risk is elevated, and the stock's current price already reflects much of the bull case without the required operating evidence.